Clinical Trials on Advanced MTAP-null Solid Tumors in Germany
Total 239 results
-
AmgenRecruitingAdvanced MTAP-null Solid TumorsUnited States, Canada, Taiwan, Switzerland, United Kingdom, Korea, Republic of, Germany, Austria, France, Belgium, Australia, Hong Kong, Japan
-
Silence Therapeutics GmbHCompleted
-
Krankenhaus NordwestTerminatedHer2/Neu Positive Advanced Solid TumorsGermany
-
Philogen S.p.A.RecruitingAdvanced Solid Tumor | Metastatic Solid TumorItaly, Germany, Switzerland
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid TumorsGermany, Czechia, United States, Brazil, Poland, Singapore, Thailand
-
T-knife GmbHTerminatedAdvanced Solid TumorsGermany, Belgium, Spain, Netherlands, United Kingdom
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedAdvanced Solid TumorsUnited States, Germany, Norway, Netherlands, Belgium, Denmark, Sweden, Switzerland
-
Vall d'Hebron Institute of OncologyTaisho Pharmaceutical Co., Ltd.; Roche Pharma AG; Iqvia Pty Ltd; Janssen, LPRecruitingAdvanced Solid TumorSpain, France, Germany, Netherlands, Sweden, United Kingdom, Italy
-
AmgenCompletedAdvanced Solid TumorsBelgium, Canada, Australia, United States, Spain, Poland, France, Germany, Japan, United Kingdom
-
AmgenRecruitingAdvanced Solid TumorsUnited States, Korea, Republic of, Spain, Australia, Germany, France, Japan, Canada
-
Novartis PharmaceuticalsRecruitingAdvanced Solid TumorsSwitzerland, Belgium, Italy, Spain, Germany, Hong Kong, Hungary, Korea, Republic of, China, Czechia, Canada, United States, France, Poland, Thailand, Netherlands, Taiwan
-
Affimed GmbHActive, not recruitingAdvanced Solid TumorUnited States, Korea, Republic of, Spain, Germany, United Kingdom
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Germany, Italy, United Kingdom, Belgium, Canada, Korea, Republic of, Taiwan, France
-
PharmaMarCompletedAdvanced Solid TumorsSpain, United States, Belgium, France, Italy, Switzerland, Germany, Sweden, United Kingdom
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Germany, Spain, Canada, France, Korea, Republic of, Israel, Netherlands, United Kingdom
-
Nuvalent Inc.RecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorCanada, United States, Korea, Republic of, Taiwan, Spain, Australia, Belgium, France, Netherlands, Singapore, Germany
-
Merck Sharp & Dohme LLCTerminatedAdvanced Solid TumorsFrance, Germany, Spain, United Kingdom
-
Immatics US, Inc.CompletedCancer | Solid Tumor | Refractory Solid Tumors | Recurrent Solid TumorsUnited States, Germany
-
Novartis PharmaceuticalsCompletedcMET Dysegulation Advanced Solid TumorsAustria, Denmark, Sweden, United Kingdom, Spain, Germany, Netherlands, United States
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Metastatic Solid TumorsFrance, Netherlands, Spain, Canada, Singapore, Germany, Korea, Republic of, Australia, Belgium, Switzerland, Italy, United States
-
Bristol-Myers SquibbActive, not recruitingAdvanced or Metastatic Solid TumorsUnited States, Spain, Italy, Canada, Germany, United Kingdom, Denmark, Finland
-
Merck Sharp & Dohme LLCTerminatedAdvanced Solid TumorsGermany, Spain, United Kingdom
-
BayerCompletedAdvanced or Metastatic Solid TumorUnited States, Spain, Korea, Republic of, Belgium, Singapore, Germany
-
Incyte CorporationCompletedLocally Advanced Solid Tumors | Metastatic Solid TumorsFrance, Spain, United States, China, United Kingdom, Lithuania, Germany, Ukraine, Finland, Italy, Belgium, Australia, Bulgaria, Latvia, New Zealand, Poland
-
Eli Lilly and CompanyCompletedSolid Tumor | Malignant Solid Tumor | Metastatic TumorGermany, United States, France
-
Janssen Research & Development, LLCActive, not recruitingAdvanced Solid TumorFrance, United States, Japan, Belgium, United Kingdom, Germany, Korea, Republic of, Taiwan, China, Poland, Italy, Spain, Australia, Brazil, Argentina
-
Philogen S.p.A.Syneos HealthCompleted
-
Novartis PharmaceuticalsCompletedMetastatic or Locally Advanced Solid TumorsNetherlands, Spain, Germany, Switzerland, Belgium
-
AmgenActive, not recruitingKRAS p.G12C Mutant Advanced Solid TumorsUnited States, France, Canada, Spain, Belgium, Korea, Republic of, Austria, Australia, Hungary, Greece, Germany, Japan, Romania, Switzerland, Brazil, Portugal
-
Novartis PharmaceuticalsCompletedAdvanced Solid and Hematological TP53wt TumorsFrance, Netherlands, Spain, Germany, Singapore, Japan, Taiwan, United States
-
BayerCompletedAdvanced Solid TumorsSpain, United States, United Kingdom, Germany, Canada
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid Tumors | Selected Solid TumorsUnited States, Germany, Canada, Spain, Netherlands, Singapore, Switzerland
-
Novartis PharmaceuticalsRecruitingAdvanced Solid Tumors Which Are cMET-dependentGermany, Korea, Republic of, Belgium, Italy, Singapore, United States, Denmark, Spain, France, Canada
-
University of CologneBoehringer IngelheimCompleted
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyNot yet recruitingAdvanced Solid TumorUnited States, Germany
-
Glycotope GmbHCompleted
-
AstraZenecaCompletedAdvanced Solid MalignanciesRussian Federation, Germany
-
Ganymed Pharmaceuticals GmbHCompletedSolid TumorsGermany, Latvia
-
PfizerCompletedNeoplasms | Solid TumorsNetherlands, Germany
-
Turning Point Therapeutics, Inc.Zai Lab (Shanghai) Co., Ltd.RecruitingLocally Advanced Solid Tumors | Metastatic Solid TumorsUnited States, China, Japan, Australia, Belgium, Canada, Denmark, France, Germany, Hong Kong, Hungary, Italy, Korea, Democratic People's Republic of, Korea, Republic of, Netherlands, Poland, Singapore, Spain, Taiwan, United Kingdom
-
Glycotope GmbHGlycotope Biotechnology GmbHCompleted
-
BayerRecruitingLocally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene FusionUnited States, Austria, Denmark, Germany, Italy, Norway, Spain, United Kingdom, Brazil, Russian Federation, Switzerland, Taiwan, Canada, China, Australia, Greece, Belgium, Sweden, Korea, Republic of, France, Argentina, Finland, Ireland and more
-
BayerCompleted
-
University Hospital, EssenCompleted
-
4SC AGCompletedMalignant Lymphomas | Advanced and Incurable Solid TumorsGermany
-
Merck KGaA, Darmstadt, GermanyThreshold PharmaceuticalsCompleted
-
AIO-Studien-gGmbHMerck Sharp & Dohme LLC; Janssen-Cilag G.m.b.H; Daiichi Sankyo Europe, GmbH,...RecruitingAdvanced Solid TumorGermany
-
AstraZenecaCompletedAdvanced Solid Tumor | Liver MetastasesGermany